MiMedx Group Stock Forecast

Stock Price Forecast

According to 6 analysts polled by S&P Global, MiMedx Group stock has a consensus rating of "Strong Buy" and an average price target of $6.50. The average 1-year stock price forecast is 75.68% higher than the current stock price, while the lowest is $5.00 (+35.14%) and the highest is $8.00 (+116.22%).

Price Target: $6.50 (+75.68%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$5.00	$6.50	$6.00	$8.00
Change	+35.14%	+75.68%	+62.16%	+116.22%

* Price targets were last updated on May 1, 2026.

Analyst Ratings

The average analyst rating for MiMedx Group stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Apr '26	May '26
Strong Buy	5	5	5	5	5	5
Buy	0	0	0	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	5	5	6	6	6

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Anthony Petrone Mizuho Securities	Mizuho Securities	Buy Maintains $10 → $8	Buy	Maintains	$10 → $8	+116.22%	May 1, 2026
Brooks O'Neil Lake Street	Lake Street	Buy Maintains $10 → $5	Buy	Maintains	$10 → $5	+35.14%	Apr 30, 2026
David Turkaly Citizens JMP	Citizens JMP	Buy Maintains $7 → $6	Buy	Maintains	$7 → $6	+62.16%	Apr 30, 2026
Chase Knickerbocker Craig-Hallum	Craig-Hallum	Buy Reiterates $7 → $6	Buy	Reiterates	$7 → $6	+62.16%	Apr 28, 2026
Carl Byrnes Northland Securities	Northland Securities	Buy Maintains $10 → $6	Buy	Maintains	$10 → $6	+62.16%	Apr 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

268.70M

from 418.63M

-35.81%

from 418.63M

Revenue Next Year

301.97M

from 268.70M

12.38%

from 268.70M

EPS This Year

-0.08

from 0.45

EPS Next Year

0.12

from -0.08

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	242.02M	267.84M	321.48M	348.88M	418.63M	268.70M
Revenue Growth	-2.50%	10.67%	20.03%	8.52%	19.99%	-35.81%
Gross Profit	202.39M	219.53M	266.84M	288.81M	345.62M	194.75M
Gross Margin	83.63%	81.96%	83.01%	82.78%	82.56%	72.48%
Operating Income	-7.00M	-14.73M	37.12M	59.31M	63.89M	-28.17M
Net Income	-10.29M	-30.20M	58.23M	42.42M	48.58M	-19.13M
EPS	-	-	-	-	0.45	-0.08
Free Cash Flow	-4.07M	-4.30M	24.82M	50.52M	63.34M	-2.30M
No. Analysts	-	-	-	-	-	6

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	275.0M
Avg	268.7M
Low	260.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	-34.3%
Avg	-35.8%
Low	-37.9%

EPS Forecast

EPS	2026	2027	2028
High	-
Avg	-0.08
Low	-

EPS Growth

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-